Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agathe Trenque

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|December 18, 2020
Drug induced stuttering: pharmacovigilance dataThierry Trenque, Aurore Morel, Agathe Trenque, et al.
European Journal of Clinical Pharmacology|January 7, 2022
Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entityThierry Trenque, Elise Lepoix, Agathe Trenque, et al.
Therapie|August 25, 2023
Statins and immune-mediated necrotizing myopathy: Variability in the riskThierry Trenque, Jed Hadjoudj, Agathe Trenque, et al.
British Journal of Clinical Pharmacology|August 17, 2019
Methylphenidate and stutteringThierry Trenque, Gwladys Claustre, Emmanuelle Herlem, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|December 18, 2020
Drug induced stuttering: pharmacovigilance dataThierry Trenque, Aurore Morel, Agathe Trenque, et al.
European Journal of Clinical Pharmacology|January 7, 2022
Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entityThierry Trenque, Elise Lepoix, Agathe Trenque, et al.
Therapie|August 25, 2023
Statins and immune-mediated necrotizing myopathy: Variability in the riskThierry Trenque, Jed Hadjoudj, Agathe Trenque, et al.
British Journal of Clinical Pharmacology|August 17, 2019
Methylphenidate and stutteringThierry Trenque, Gwladys Claustre, Emmanuelle Herlem, et al.
Pageof 1